CX3CL1 and neoplasm: Thus, CXCL9, CXCL10, CXCL16, CCL5, and CX3CL1 can be used to efficiently mobilize CTLs from regional lymph nodes to tumor tissues with an objective to enhance CTL-mediated tumor destruction.